Author:
Carpenter Michelle A.,Novack Gary D.
Reference18 articles.
1. Regulatory review intervals for ophthalmic new drug applications (NDAs) at the U.S. Food and drug administration (FDA);Novack;Am J Ophthalmol,1998
2. Pipeline: the accelerated drug approval;Novack;Ocul Surf,2010
3. Competitive development in pharmacologic classes: market entry and the timing of development;DiMasi;Clin Pharmacol Ther,2016
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献